Haemonetics | HAE

Stock Price
54.38
Daily Change
0.30 0.55%
Monthly
-28.23%
Yearly
-25.75%
Q3 Forecast
53.93

Peers Price Chg Day Year Date
Terumo 2,645.50 20.00 0.76% -0.02% Sep/05
Avanos Medical 12.72 0.06 0.47% -46.37% Sep/05
Baxter International 24.42 0.84 3.56% -37.34% Sep/05
Becton, Dickinson and Co. 192.39 1.13 0.59% -17.28% Sep/05
Boston Scientific 107.22 -0.07 -0.07% 31.36% Sep/05
Cooper Companies 68.09 0.09 0.13% -36.13% Sep/05
Fresenius Medical Care 41.99 0.28 0.67% 16.83% Sep/06
Fresenius 46.82 -0.36 -0.76% 39.22% Sep/06
Globus Medical 60.60 0.31 0.51% -13.42% Sep/05
Haemonetics 54.38 0.30 0.55% -25.75% Sep/05
Hologic 66.76 0.37 0.56% -18.16% Sep/05
ICU Medical 131.24 5.61 4.47% -19.15% Sep/05
Intuitive Surgical 466.86 12.34 2.72% -1.06% Sep/05
Masimo 147.19 4.18 2.92% 31.97% Sep/05
Medtronic 92.93 0.13 0.14% 3.32% Sep/05
Merit Medical Systems 92.97 0.82 0.89% -3.74% Sep/05
Neogen 5.75 0.01 0.17% -62.71% Sep/05
Quidel 28.68 0.89 3.20% -33.99% Sep/05
ResMed 277.05 3.24 1.18% 13.23% Sep/05
STAAR Surgical 27.94 0.16 0.58% -10.22% Sep/05
Steris 245.30 1.91 0.78% 2.42% Sep/05
Stryker 392.31 -2.03 -0.51% 9.17% Sep/05
Teleflex 130.70 1.61 1.25% -46.61% Sep/05
Thermo Fisher Scientific 492.60 3.11 0.64% -19.59% Sep/05
US Physical Therapy 85.64 -0.17 -0.20% 1.28% Sep/05
Zimmer Biomet Holdings 105.73 0.97 0.93% 0.76% Sep/05

Indexes Price Day Year Date
US2000 2391 11.44 0.48% 14.33% Sep/05
US400 3297 16.31 0.50% 12.16% Sep/05

Haemonetics traded at $54.38 this Friday September 5th, increasing $0.30 or 0.55 percent since the previous trading session. Looking back, over the last four weeks, Haemonetics gained 28.23 percent. Over the last 12 months, its price fell by 25.75 percent. Looking ahead, we forecast Haemonetics to be priced at 53.93 by the end of this quarter and at 52.60 in one year, according to Trading Economics global macro models projections and analysts expectations.

Haemonetics Corporation (Haemonetics) is a healthcare company. The Company provides a suite of medical products and solutions for customers, to help them improve patient care and reduce the cost of healthcare. Its technology addresses medical markets: blood and plasma component collection, the surgical suite and hospital transfusion services. Its segments include Plasma, Blood Center and Hospital. Its Plasma segment offers automated plasma collection and donor management software systems that improve the donor experience at plasma collection centers. Its Blood Center segment offers a range of solutions that improve donor collection centers' ability to acquire blood, filter blood and separate blood components. Its Hospital segment provides the patient care. It markets and sells its products to biopharmaceutical companies, blood collection groups and independent blood centers, hospitals and hospital service providers, group purchasing organizations and national health organizations.